Null Genotypes of GSTM1 and GSTT1 Contribute to Risk of Cervical Neoplasia: An Evidence-Based Meta-Analysis
2011

Null Genotypes of GSTM1 and GSTT1 Contribute to Risk of Cervical Neoplasia

Sample size: 5102 publication Evidence: moderate

Author Information

Author(s): Gao Lin-Bo, Pan Xin-Min, Li Li-Juan, Liang Wei-Bo, Bai Peng, Rao Li, Su Xiao-Wei, Wang Tao, Zhou Bin, Wei Yong-Gang, Zhang Lin

Primary Institution: West China Institute of Women and Children's Health, Sichuan University

Hypothesis

Do GSTM1 and GSTT1 polymorphisms increase the risk of cervical neoplasia?

Conclusion

The null genotypes of GSTM1 and GSTT1 polymorphisms are associated with a significantly increased risk of cervical neoplasia.

Supporting Evidence

  • The null genotype of GSTM1 was associated with an increased risk of cervical neoplasia (OR=1.40).
  • The null genotype of GSTT1 was associated with an increased risk of cervical neoplasia (OR=1.30).
  • Individuals with dual null genotype had a significantly increased risk of cervical neoplasia (OR=1.72).
  • Subgroup analyses showed increased risks in Asian populations for both GSTM1 and GSTT1.
  • Studies with DNA extracted from white blood cells showed increased risks for GSTM1.
  • Significant heterogeneity was observed across studies.

Takeaway

Some people have a gene that doesn't work properly, which can make them more likely to get a certain kind of cancer called cervical neoplasia.

Methodology

This study is a meta-analysis combining data from 25 case-control studies to evaluate the association between GSTM1 and GSTT1 polymorphisms and cervical neoplasia risk.

Potential Biases

Potential confounding factors such as age, sexual habits, and menopausal status could not be ruled out due to unadjusted data.

Limitations

There is significant heterogeneity between studies and a relatively small sample size in some analyses.

Participant Demographics

The studies included participants from various ethnic backgrounds, primarily Asians and Caucasians.

Statistical Information

Confidence Interval

95%CI, 1.19–1.65 for GSTM1; 95%CI, 1.05–1.62 for GSTT1

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0020157

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication